This study identified 621 SNPs that differed significantly between asymptomatic and acutely afflicted COVID-19 patients, and were associated with IFN and IL signaling, as well as obesity and cholesterol metabolism that are well-known COVID-19 comorbidities. This evidence concerns the gene IFNA1 and COVID-19.